TGen News & Press Releases

TGen Names former Dell Executive to Board of Directors

Posted Thursday September 9, 2021

Karen Quintos one of 5 across City of Hope enterprise whose skillsets will be valuable assets to the existing boards of directors, which are filled with accomplished leaders in diverse fields

Helios Scholars at TGen learn teamwork, technique and tenacity

Posted Monday August 2, 2021

Aug. 3 symposium caps 8-week internship of real-life biomedical research sponsored by Helios Education Foundation

Measuring the effects of radiotherapy on cancer may open up new avenues of treatment

Posted Thursday May 27, 2021

International team identifies biomarker that suggests a better way to monitor radiation therapy

WENDY’S® JR. FROSTY® PROMOTION BENEFITS TGEN CANCER RESEARCH

Posted Monday April 5, 2021

$200,000 Hearst Foundation grant supports TGen pancreatic cancer research

Posted Monday April 5, 2021

Funds launch study into condition known as malignant ascites

TGen-led study confirms cell-free DNA in urine as potential method for cancer detection

Posted Wednesday February 17, 2021

If successful, non-invasive method could transform detection and treatment outcomes

Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hope’s Genomics Institute, TGen

Posted Tuesday February 16, 2021

Provides Access to Industry-Leading Sequencing Lab and Plans for 10-Year Partnership with National Cancer Research Leaders

TGen-led study results suggest a more accurate diagnostic for breast cancer

Posted Tuesday January 26, 2021

Proteomics-based technology could help verify mammography screening

Exact Sciences Licenses Targeted Digital Sequencing Method to Extend Leadership in Precision Oncology

Posted Wednesday January 13, 2021

Worldwide Exclusive License Provides Access to Targeted Digital Sequencing (TARDIS) Blood Biopsy Method for Use in Minimal Residual Disease Testing

Compound derived from thunder god vine could help pancreatic cancer patients

Posted Monday December 14, 2020

TGen-led study indicates drug attacks ‘super-enhancers’ in the DNA of cancer cells and in the stromal cocoon that hides the tumor from the immune system

Prev
1
2
[3]
4
5
Next

Media Contact

Galen Perry
[email protected]
602-343-8423

News Archive

View Media Release Archive

TGen is a partner with OncLive

Media Contact

Newsletter

News Archive

Latest Posts

Useful Links

Contact Us

Stay up-to-date with TGen